Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 1038 
ORIGINAL ARTICLE
Year : 2011  |  Volume : 17  |  Issue : 3  |  Page : 170-173

Clinical relevance of serum vascular endothelial growth factor and Interleukin-6 in patients with colorectal cancer


1 Department of Internal Medicine, Specialized Medical Hospital, Faculty of Medicine, Mansoura University, Egypt
2 Department of General Surgery, Mansoura Faculty of Medicine, Mansoura University, Egypt
3 Department of Clinical Pathology, Clinical Immunology Unit, Faculty of Medicine, Mansoura University, Egypt
4 Department of Pathology, Mansoura University Hospitals, Faculty of Medicine, Mansoura University, Egypt

Correspondence Address:
Ayman Eldesoky
Department of Internal Medicine, Faculty of Medicine, Mansoura University
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1319-3767.80378

Rights and Permissions

Background/Aim: Some biological factors play a role in stimulation of malignant growth, metastasis and angiogenesis; however, their clinical relevance has not yet been well established for most of them. This work was aimed at studying the clinical relevance of serum vascular endothelial growth factor (VEGF) and interleukin -6 (IL-6), in patients with colorectal cancer (CRC). Materials and Methods: Preoperative serum levels of VEGF and IL-6 were measured by enzyme -linked immuno -assay in 35 CRC patients and in 30 healthy controls. Results: CRC patients with or without metastasis had significantly higher VEGF and IL-6 levels than healthy controls (all P < 0.001). Patients with advanced clinical stage had significantly higher levels of VEGF and IL-6 than those with early clinical stage (all P < 0.001). Also, patients with metastatic disease had significantly higher VEGF and IL-6 levels than those with localized disease (all P < 0.001). The diagnostic accuracy for invasiveness was 83% for VEGF (cut off value = 240 pg/ml) and 66% for IL-6 (cut off value = 6.7 pg/ml), with sensitivity 79% and 74% and specificity 68% and 59%, respectively. Conclusion: In CRC patients, preoperative measurement of serum VEGF and Il-6 may prove useful non-invasive diagnostic indicators associated with advanced clinical stage and tumor metastasis that warrants further investigations.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2816    
    Printed203    
    Emailed0    
    PDF Downloaded569    
    Comments [Add]    
    Cited by others 7    

Recommend this journal